EUVIMEDObjevte EUVIMED
Crossref

HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study

Zhiyuan Li, Qing Shao, Hongqun Qiao iD

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70366 ↗

At a glance

Journal article in Biomedical Chromatography, 2026. Written by Zhiyuan Li and 2 co-authors. Institution: School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China. Major MEDLINE topics: Tandem Mass Spectrometry, Sodium-Glucose Transporter 2 Inhibitors, Liquid Chromatography-Mass Spectrometry. 26 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

A sensitive and robust HPLC‐MS/MS method was developed and validated for the simultaneous determination of YWS22026 and its major metabolite M3 in rat plasma using protein precipitation. Chromatographic separation was achieved on a Shim‐pack Scepter C18 column (4.6 × 50 mm, 3 μm) with a gradient elution program (mobile phase A: 0.2% formic acid in water; mobile phase B: methanol) at a flow rate of 0.9 mL/min. Detection was performed via positive electrospray ionization (ESI+) in multiple reaction monitoring (MRM) mode. The method demonstrated excellent specificity, accuracy (relative error, %RE < 9.1%), precision (relative standard deviation, %RSD < 9.9%), and linearity (5–2000 ng/mL for both analytes). The lower limit of quantification (LLOQ) was 5 ng/mL. Stability studies confirmed that plasma samples remained stable under various storage conditions (at room temperature for 10 h, −20°C for 22 days, three freeze–thaw cycles, and 4°C autosampler storage for 73 h). This validated method was successfully applied to a 26‐week concomitant toxicokinetic study in Sprague–Dawley rats, which revealed significant sex‐related differences in exposure for both YWS22026 and M3. These findings provide valuable insights for informing the safety assessment of YWS22026 in subsequent clinical trials.

Subjects

MeSH terms (MEDLINE)

Tandem Mass SpectrometrySodium-Glucose Transporter 2 InhibitorsLiquid Chromatography-Mass SpectrometryAnimalsChromatography, High Pressure LiquidRatsReproducibility of ResultsRats, Sprague-DawleyMaleLinear ModelsLimit of DetectionToxicokineticsDrug Stability

Author keywords

HPLC‐MS/MSYWS22026metabolitetoxicokinetics

Substances

Sodium-Glucose Transporter 2 Inhibitors

Authors and institutions

  • School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China.
  • Jiangsu Center for Safety Evaluation of Drugs, Jiangsu Provincial Institute of Materia Medica, Nanjing, China.

ORCID profiles: Hongqun Qiao

Cite

APA

Li, Z., Shao, Q., & Qiao, H. (2026). HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.70366

Vancouver

Li Z, Shao Q, Qiao H. HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study. Biomedical Chromatography. 2026. doi:10.1002/bmc.70366

BibTeX
@article{Li2026,
  author = {Li, Zhiyuan and Shao, Qing and Qiao, Hongqun},
  title = {HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70366}
}
Start for free →